Digoxin Dosing for a 6 kg Infant with Heart Failure
For a 6 kg infant with heart failure, digoxin should NOT be routinely used unless there is a specific indication such as atrial fibrillation or arrhythmia control, as there is no pediatric evidence supporting its use in structurally normal hearts with systolic dysfunction. 1
Current Guideline Recommendations
The Canadian Cardiovascular Society guidelines explicitly state that there are no pediatric data supporting the use of digoxin in children with structurally normal hearts and systolic dysfunction, and therefore no recommendation can be made for routine digoxin use in children with heart failure 1. The traditional use of digoxin in infants with large ventricular septal defects and pulmonary congestion has not been shown to improve contractility or clinical symptoms 1.
If Digoxin Is Indicated (e.g., for arrhythmia control)
Dosing Schedule for a 6 kg Infant:
Daily Maintenance Dose:
- For infants 2-5 years: 10-15 mcg/kg/day 2
- For this 6 kg infant: 60-90 mcg/day (divided into 2 doses)
- Start at the lower end: 30 mcg twice daily (total 60 mcg/day)
Critical Dosing Considerations:
Renal function is paramount - The newborn period has diminished renal clearance of digoxin, requiring careful dose adjustments 2. This is especially pronounced in premature infants 2.
Age-specific factors:
- Infants require proportionally larger doses than adults based on body weight due to larger volume of distribution and more rapid clearance 3, 4
- However, premature and very low birth weight infants are more sensitive to digoxin and require smaller doses 5, 4
- The linear regression slope between dose and plasma concentration is greater in younger age groups 4
Monitoring Protocol:
- Check serum creatinine BEFORE starting - Digoxin clearance correlates directly with renal function 2, 6
- Target serum digoxin level: 1.0-1.7 ng/mL (NOT higher) 3
- Measure digoxin level:
- 7-14 days after initiation (before steady state at ~11 days) 2
- With any dose change
- If clinical deterioration or suspected toxicity
- Monitor for renal dysfunction - This is independently associated with supratherapeutic levels (adjusted OR 6.1 for severe dysfunction) 7
Critical Pitfalls to Avoid:
Do NOT use higher doses thinking infants need higher serum levels - This is a dangerous misconception. While infants tolerate higher levels due to decreased conduction system sensitivity, they do NOT require them for therapeutic effect 3. High levels (>2 ng/mL) are associated with greater toxicity, especially with concomitant diuretic therapy 3.
Premature infants require LOWER doses - Studies show that premature infants digitalized with 20 mcg/kg (rather than 30 mcg/kg) achieved therapeutic cardiac effects with serum levels below the toxic range 5. The half-life in premature infants is twice that of term infants 5.
Adjust for interacting medications - 76% of children with elevated digoxin levels were on interacting medications 7.
Sequential Heart Failure Therapy Algorithm (Without Digoxin)
Based on the Canadian guidelines, the appropriate sequential approach for pediatric heart failure is 1:
- First-line: ACE inhibitor + Diuretic
- Second-line: Add β-blocker (carvedilol)
- Third-line: Add aldosterone antagonist (spironolactone 1 mg/kg/day, max 2 mg/kg/day)
- Check potassium and renal function before starting, at 7-14 days, then periodically
- Re-evaluate any potassium supplementation
If digoxin is already being used with carvedilol, digoxin dosing may require reduction 1.
Key Point on Dose-Response:
Smaller dose changes in young infants produce larger changes in serum concentration compared to older children, where larger dose adjustments are necessary to achieve the same concentration change 4. This means titrate cautiously in infants.